Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

254 ARTÍCULOS , VIENDO DEL 106 AL 120

Primary progressive aphasia: ReADing the clinical GRANularity

Chokesuwattanaskul A, Marshall CR, van Harskamp N, Houlden H, Rohrer JD, Hardy CJ, Warren JD.

Pract Neurol. 2022 Dec;22(6):509-514. doi: 10.1136/practneurol-2022-003460. Epub 2022 Jun 16.

Staging of Alzheimer's disease: past, present, and future perspectives

Therriault J, Zimmer ER, Benedet AL, Pascoal TA, Gauthier S, Rosa-Neto P.

Trends Mol Med. 2022 Sep;28(9):726-741. doi: 10.1016/j.molmed.2022.05.008. Epub 2022 Jun 15.

Attention-guided neural network for early dementia detection using MRS data

Kherchouche A, Ben-Ahmed O, Guillevin C, Tremblais B, Julian A, Fernandez-Maloigne C, Guillevin R.

Comput Med Imaging Graph. 2022 Jul;99:102074. doi: 10.1016/j.compmedimag.2022.102074. Epub 2022 May 27.

Predictive Accuracy of Digital Biomarker Technologies for Detection of Mild Cognitive Impairment and Pre-Frailty Amongst Older Adults: A Systematic Review and Meta-Analysis

Teh SK, Rawtaer I, Tan HP.

IEEE J Biomed Health Inform. 2022 Aug;26(8):3638-3648. doi: 10.1109/JBHI.2022.3185798. Epub 2022 Aug 11.

New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer's Disease and Its Potential for Therapeutic Intervention

Li T, Lu L, Pember E, Li X, Zhang B, Zhu Z.

Cells. 2022 Jun 14;11(12):1925. doi: 10.3390/cells11121925.

Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer's Disease

Bousiges O, Blanc F.

Int J Mol Sci. 2022 Jun 7;23(12):6371. doi: 10.3390/ijms23126371.

MicroRNA-29c-3p in dual-labeled exosome is a potential diagnostic marker of subjective cognitive decline

Li Y, Xia M, Meng S, Wu D, Ling S, Chen X, Liu C.

Neurobiol Dis. 2022 Sep;171:105800. doi: 10.1016/j.nbd.2022.105800. Epub 2022 Jun 22.

Association between obstructive sleep apnea and Alzheimer's disease-related blood and cerebrospinal fluid biomarkers: A meta-analysis

Kang J, Tian Z, Wei J, Mu Z, Liang J, Li M.

J Clin Neurosci. 2022 Aug;102:87-94. doi: 10.1016/j.jocn.2022.06.004. Epub 2022 Jun 23.

Endosomal-Lysosomal and Autophagy Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis

Krance SH, Wu CY, Chan ACY, Kwong S, Song BX, Xiong LY, Ouk M, Chen MH, Zhang J, Yung A, Stanley M, Herrmann N, Lanctôt KL, Swardfager W.

J Alzheimers Dis. 2022;88(4):1279-1292. doi: 10.3233/JAD-220360.

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers

Janelidze S, Christian BT, Price J, Laymon C, Schupf N, Klunk WE, Lott I, Silverman W, Rosas HD, Zaman S, Mapstone M, Lai F, Ances BM, Handen BL, Hansson O.

JAMA Neurol. 2022 Aug 1;79(8):797-807. doi: 10.1001/jamaneurol.2022.1740.

Tau as a Biomarker of Neurodegeneration

Holper S, Watson R, Yassi N.

Int J Mol Sci. 2022 Jun 30;23(13):7307. doi: 10.3390/ijms23137307.

Peptidomic Approaches and Observations in Neurodegenerative Diseases

Muqaku B, Oeckl P.

Int J Mol Sci. 2022 Jun 30;23(13):7332. doi: 10.3390/ijms23137332.

A Comparison of Operational Definitions for Mild Cognitive Impairment

Polcher A, Wolfsgruber S, Peters O, Frölich L, Wiltfang J, Kornhuber J, Hüll M, Rüther E, Lewczuk P, Maier W, Jessen F, Wagner M.

J Alzheimers Dis. 2022;88(4):1663-1678. doi: 10.3233/JAD-215548.

The Open-Access European Prevention of Alzheimer's Dementia (EPAD) MRI dataset and processing workflow

Lorenzini L, Ingala S, Wink AM, Kuijer JPA, Wottschel V, Dijsselhof M, Sudre CH, Haller S, Molinuevo JL, Gispert JD, Cash DM, Thomas DL, Vos SB, Prados F, Petr J, Wolz R, Palombit A, Schwarz AJ, Chételat G, Payoux P, Di Perri C, Wardlaw JM, Frisoni GB, Foley C, Fox NC, Ritchie C, Pernet C, Waldman A, Barkhof F, Mutsaerts HJMM; EPAD consortium.

Neuroimage Clin. 2022;35:103106. doi: 10.1016/j.nicl.2022.103106. Epub 2022 Jul 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias